KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Capital Expenditures (2017 - 2025)

Stereotaxis (STXS) has disclosed Capital Expenditures for 12 consecutive years, with $2000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Capital Expenditures changed N/A to $2000.0 in Q4 2024 year-over-year; TTM through Sep 2025 was $12000.0, a 55.56% decrease, with the full-year FY2024 number at $34000.0, down 90.71% from a year prior.
  • Capital Expenditures was $2000.0 for Q4 2024 at Stereotaxis, down from $10000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.2 million in Q4 2021 to a low of $2000.0 in Q4 2024.
  • A 4-year average of $319461.5 and a median of $116000.0 in 2021 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: surged 3294.12% in 2022, then tumbled 98.92% in 2023.
  • Stereotaxis' Capital Expenditures stood at $1.2 million in 2021, then plummeted by 69.15% to $369000.0 in 2022, then tumbled by 97.29% to $10000.0 in 2023, then plummeted by 80.0% to $2000.0 in 2024.
  • Per Business Quant, the three most recent readings for STXS's Capital Expenditures are $2000.0 (Q4 2024), $10000.0 (Q3 2024), and $10000.0 (Q3 2023).